Poster #T12 LIFETIME SYMPTOM DIMENSIONS AND THEIR CORRELATION WITH COGNITIVE FUNCTION FUNCTIONAL LEVEL AND TREATMENT RESPONSE IN CHRONIC SCHIZOPHRENIA PATIENTS

2014 ◽  
Vol 153 ◽  
pp. S293
Author(s):  
Moonoh Bae ◽  
Youngah Cho ◽  
Seunghyong Ryu ◽  
Hyeji Oh ◽  
Sohee Oh ◽  
...  
Keyword(s):  
Cognitive Function ◽  
Treatment Response ◽  
Chronic Schizophrenia ◽  
Functional Level ◽  
Symptom Dimensions

scholarly journals BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review

2021 ◽  
Vol 12 ◽  
Author(s):  
Rodrigo R. Nieto ◽  
Andrea Carrasco ◽  
Sebastian Corral ◽  
Rolando Castillo ◽  
Pablo A. Gaspar ◽  
...  
Keyword(s):  
Cognitive Function ◽  
High Risk ◽  
Human Subjects ◽  
Chronic Schizophrenia ◽  
Review Article ◽  
First Episode ◽  
Cognitive Symptoms ◽  
Research Gaps ◽  
Future Developments ◽  
The Relationship

Brain Derived Neurotrophic Factor (BDNF) has been linked to cognitive symptoms of schizophrenia, which has been documented in previous reviews by several authors. However, a trend has recently emerged in this field moving from studying schizophrenia as a disease to studying psychosis as a group. This review article focuses on recent BDNF studies in relation to cognition in human subjects during different stages of the psychotic process, including subjects at high risk of developing psychosis, patients at their first episode of psychosis, and patients with chronic schizophrenia. We aim to provide an update of BDNF as a biomarker of cognitive function on human subjects with schizophrenia or earlier stages of psychosis, covering new trends, controversies, current research gaps, and suggest potential future developments in the field. We found that most of current research regarding BDNF and cognitive symptoms in psychosis is done around schizophrenia as a disease. Therefore, it is necessary to expand the study of the relationship between BDNF and cognitive symptoms to psychotic illnesses of different stages and origins.

AUTOBIOGRAPHICAL MEMORY DEFICITS AND THEIR RELATIONSHIP WITH SYMPTOM DIMENSIONS IN OLDER PATIENTS WITH CHRONIC SCHIZOPHRENIA

2010 ◽  
Vol 117 (2-3) ◽  
pp. 216
Author(s):  
Lena A. Schmid ◽  
Marc M. Lässer ◽  
Christina J. Herold ◽  
Ulrich Seidl ◽  
Johannes Schröder
Keyword(s):  
Autobiographical Memory ◽  
Older Patients ◽  
Chronic Schizophrenia ◽  
Memory Deficits ◽  
Symptom Dimensions

Does GRIN2B gene influence obsessive-compulsive disorder risk, symptom dimensions and treatment response?

2018 ◽  
Vol 31 ◽  
pp. 150-151 ◽  
Author(s):  
Biju Viswanath ◽  
Reshma Jabeen Taj MJ ◽  
Ravi Kumar Nadella ◽  
Tulika Shukla ◽  
Madhuri H. Nanjundaswamy ◽  
...  
Keyword(s):  
Treatment Response ◽  
Obsessive Compulsive Disorder ◽  
Obsessive Compulsive ◽  
Symptom Dimensions ◽  
Compulsive Disorder ◽  
Risk Symptom ◽  
Disorder Risk

Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder

2017 ◽  
Vol 19 (7) ◽  
pp. 552-562 ◽  
Author(s):  
Satoshi Saito ◽  
Kumiko Fujii ◽  
Yuji Ozeki ◽  
Kenichi Ohmori ◽  
Gyo Honda ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Cognitive Function ◽  
Treatment Response ◽  
Social Functioning ◽  
Japanese Patients

scholarly journals Gender differences in cognitive function of patients with chronic schizophrenia

2012 ◽  
Vol 39 (2) ◽  
pp. 358-363 ◽  
Author(s):  
Mei Han ◽  
Xu-Feng Huang ◽  
Da Chun Chen ◽  
Mei Hong Xiu ◽  
Li Hui ◽  
...  
Keyword(s):  
Gender Differences ◽  
Cognitive Function ◽  
Chronic Schizophrenia

Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia

2011 ◽  
Vol 186 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Tomiki Sumiyoshi ◽  
Yuko Higuchi ◽  
Mie Matsui ◽  
Hiroko Itoh ◽  
Takashi Uehara ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Treatment Response ◽  
Chronic Schizophrenia ◽  
Membrane Fatty Acid
Sign in / Sign up

Export Citation Format

Share Document